Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-09-10
2010-12-07
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S293000
Reexamination Certificate
active
07846938
ABSTRACT:
The present invention relates to tartrate salts of quinazoline containing zinc-binding moiety based derivatives of Formula II, below.These compounds are inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and may further act as HDAC inhibitors. The invention further relates to the use of these tartrate salts in the treatment of EGFR-TK related diseases and disorders such as cancer.
REFERENCES:
patent: 5457105 (1995-10-01), Barker
patent: 5556860 (1996-09-01), Muraoka et al.
patent: 5616582 (1997-04-01), Barker et al.
patent: 5747498 (1998-05-01), Schnur et al.
patent: 5942514 (1999-08-01), Barker et al.
patent: 6087367 (2000-07-01), Breslow et al.
patent: 6184225 (2001-02-01), Thomas et al.
patent: 6537988 (2003-03-01), Lee
patent: 6777217 (2004-08-01), Schreiber et al.
patent: 6900221 (2005-05-01), Norris et al.
patent: 7250514 (2007-07-01), Xiao
patent: 7230000 (2007-12-01), Finer et al.
patent: 2006/0025430 (2006-02-01), Mishani et al.
patent: 2006/0111375 (2006-05-01), Shimizu et al.
patent: 2006/0287295 (2006-12-01), Balaram et al.
patent: 2008/0125448 (2008-05-01), Qian et al.
patent: 2008/0139590 (2008-06-01), Qian et al.
patent: 2008/0194578 (2008-08-01), Qian et al.
patent: 2008/0221132 (2008-09-01), Cai et al.
patent: 9633980 (1996-10-01), None
patent: 00/47212 (2000-08-01), None
patent: 0268396 (2002-06-01), None
patent: 2004069791 (2004-08-01), None
patent: 2005097137 (2005-10-01), None
patent: 2006082428 (2006-08-01), None
patent: 2006/113498 (2006-10-01), None
patent: 2006110811 (2006-10-01), None
patent: 2006111570 (2006-10-01), None
patent: 2007131364 (2007-11-01), None
patent: WO2008/033747 (2008-03-01), None
patent: 2008055068 (2008-08-01), None
Berge et al. Pharmaceutical Salts, 1977, Journal of Pharmaceutical Sciences, 66, 1-19.
Wood, Edgar R. et. al., “A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib): Relationships among Protein Conformation, Inhibitor Off-Rate, and Receptor Activity in Tumor Cells,” Cancer Research, 64: 6652-6659 (2004).
Matsuno, Kenji, et. al, “Potent and Selective Inhibitors of Platelet-Derived Growth Factor Receptor Phosphorylation. 3. Replacement of Quinazoline Moiety and Improvement of Metabolic Polymorphism of 4-[4-(N-Substituted (thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline Derivatives,” Journal of Medicinal Chemistry, 46: 4910-4925 (2003).
Ple, Patrick A., et. al., Discovery of a New Class of Anilinoquinazoline Inhibitors with High Affinity and Specificity for the Tyrosine Kinase Domain of c-Src, Journal of Medicinal Chemistry, 47: 871-887 (2004).
Banker, G.S. et al, “Modern Pharmaceutics, 3ed.”, Marcel Dekker, New York, 1996, pp. 451 and 596.
Wolff, Manfred E., “Burger's Medicinal Chemistry, 5ed, Part I”, John Wiley & Sons, 1995, pp. 975-977.
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 and 365.
Hennequin, et al., “Design and Structure-Activity Relationship of a New Class of Potent VEGF Receptor Tyrosine Kinase Inhibitors,” J. Med. Chem., 30: 5369-5389 (1999).
Butler, Lisa M., et al., “Suberoylanilide Hydroxamic Acid, an Inhibitor of Histone Deacetylase, Suppresse the Growth of Prostate Cancer Cells in Vitro and in Vivo,” Cancer Research, 60: 5165-5170 (2000).
Cai Xiong
Qian Changgeng
Zhai Haixiao
Curis, Inc.
Elmore Carolyn S.
Elmore Patent Law Group P.C.
Harlan Edgar W.
McDowell Brian
LandOfFree
Tartrate salts of quinazoline based EGFR inhibitors... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tartrate salts of quinazoline based EGFR inhibitors..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tartrate salts of quinazoline based EGFR inhibitors... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4208565